Dutch life sciences investor Forbion Capital Partners is rolling out operations at a new office in Munich and has appointed a partner, Dr Holger Reithinger, to head the team. The company has also led a $12m Series C funding round for biotech company Promedior Inc.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.